GLP1R and colorectal carcinoma: Moreover, GLP-1 RAs may promote a shift in macrophage polarization from the M2 to the M1 phenotype, thereby restoring antitumour immune responses and enhancing the potential efficacy of immune checkpoint blockade, an area of growing interest in both CRC and PDAC, where response rates to immunotherapy remain modest.